BusinessPatient-Friendly Clinical Trials Finder Gives Access to Clinical Trials in Real-TimeBy Nasdaq OMXJul 11, 2017, 8:04 PM UTC
BusinessINC Research Further Expands Catalyst Program with Launch of Psychiatry Catalyst Site NetworkBy Nasdaq OMXJul 5, 2017, 2:31 PM UTC
BusinessCascadian Therapeutics’ Lead Candidate, Tucatinib, Receives Orphan Drug Designation from FDA for Treatment of Breast Cancer Patients with Brain MetastasesBy Nasdaq OMXJun 8, 2017, 12:01 PM UTC
BusinessAtlant Clinical to host first MedDRA Face-to-Face Trainings in RussiaBy Nasdaq OMXMay 31, 2017, 4:51 PM UTC
BusinessAtlant Clinical to host first MedDRA Face-to-Face Trainings in RussiaBy Nasdaq OMXMay 31, 2017, 4:51 PM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
